Exploring the synergy of CRISPR and microphysiological systems

Area of Science:

• Biotechnology
• Genetics
• Cell Biology

Background:

• The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) associated nuclease 9 (CRISPR-Cas9) system is a powerful gene editing tool derived from bacterial immunity.
• CRISPR-Cas9 holds significant promise for treating genetic diseases by correcting pathogenic mutations.
• Current limitations in predictive models hinder the advancement of CRISPR-Cas9 gene therapies.

Purpose of the Study:

• To explore the utility of microphysiological systems (MPS) as a model for CRISPR-Cas9 safety studies.
• To address the need for translatable models that can predict both intended and unintended effects of CRISPR-Cas9 editing.
• To facilitate the clinical progression of CRISPR-based gene therapies.

Main Methods:

• Investigated the application of microphysiological systems (MPS) for evaluating CRISPR-Cas9 gene editing outcomes.
• Compared the efficacy of MPS against traditional models like cell lines and small mammals for safety assessments.
• Focused on the potential of MPS to model CRISPR-Cas9 effects in a more physiologically relevant context.

Main Results:

• Microphysiological systems (MPS) show potential as an alternative to current models for CRISPR safety studies.
• MPS may provide a more accurate and translatable platform for assessing CRISPR-Cas9 editing outcomes.
• This approach could overcome limitations associated with traditional in vitro and in vivo models.

Conclusions:

• Microphysiological systems (MPS) represent a promising advancement for CRISPR-Cas9 safety and efficacy testing.
• Adoption of MPS could accelerate the development and clinical application of gene therapies.
• Further research into MPS models is crucial for realizing the full potential of CRISPR-Cas9 technology.